Biopharma Contract Manufacturing Market (3rd Edition), 2019-2030

KAUAI, Hawaii - Oct. 13, 2020 - PRLog -- The report features an extensive study on the contract service providers within the biopharmaceutical industry. The study features in-depth analysis, highlighting the capabilities of a diverse set of biopharmaceutical CMOs and CDMOs. Amongst other elements, the report includes:

§  A detailed review of the overall landscape of the biopharmaceutical contract manufacturing market, featuring a comprehensive list of active CMOs and detailed analysis of the manufacturing service providers based on a number of parameters.

§  Elaborate profiles of key players that have a diverse range of capabilities for the development, manufacturing, and packaging of biologics.

§  A detailed discussion on the key enablers in this domain, including certain niche product classes, which are likely to have a significant impact on the growth of the contract services market.

§  A case study on the growing global biosimilars market, highlighting the opportunities for biopharmaceutical CMOs and CDMOs.

§  A case study comparing the key characteristics of large molecule and small molecule drugs, along with details on the various steps involved in their respective manufacturing processes.

§  A discussion on challenges related to in-house manufacturing, featuring a brief overview of the various parameters that a drug / therapy developer may need to take into consideration while deciding whether to manufacture its products in-house or outsource.

§  An analysis of the recent collaborations (signed since 2013) focused on the contract manufacturing of biologics.

§  A detailed analysis of the various mergers and acquisitions that have taken place in this domain, highlighting the trend in the number of companies acquired between 2013-2018, along with the geographical distribution of this activity.

§  An in-depth analysis of more than 490 grants that have been awarded to research institutes engaged in next generation immune checkpoint therapy-related projects.

§  An analysis on the recent trends within biopharmaceutical contract manufacturing industry, highlighting various facility and capability expansions.

§  A detailed capacity analysis, taking into consideration the individual development and manufacturing capacities of various stakeholders.

§  A detailed capacity analysis, taking into consideration the individual development and manufacturing capacities of various stakeholders.

§  A discussion on affiliated trends, key drivers, and challenges, under a comprehensive SWOT framework.

For more information please click on the following link:

Biopharma Contract Manufacturing Market (3^rd Edition), 2019-2030 (https://rootsanalysis.com/reports/view_document/biopharma...)

Other Recent Offerings

1.      Cell Therapy Manufacturing Market (3^rd Edition), 2019-2030 (https://www.rootsanalysis.com/reports/view_document/cell-...)

2.      Antibody Contract Manufacturing Market, 2020-2030 (https://www.rootsanalysis.com/reports/view_document/antibody-cmo-market/295.html)

3.      China Biopharmaceutical Contract Manufacturing Market, 2020-2030

4.      Peptide Therapeutics: Contract API Manufacturing Market, 2020-2030

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

gaurav.chaudhary@rootsanalysis.com